These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9347498)

  • 1. Thalidomide-induced perioral neuropathy.
    Elad S; Galili D; Garfunkel AA; Or R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Oct; 84(4):362-4. PubMed ID: 9347498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide-induced neuropathy.
    Chaudhry V; Cornblath DR; Corse A; Freimer M; Simmons-O'Brien E; Vogelsang G
    Neurology; 2002 Dec; 59(12):1872-5. PubMed ID: 12499476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-threatening acute pancreatitis due to thalidomide therapy for chronic graft-versus-host disease.
    Chung LW; Yeh SP; Hsieh CY; Liao YM; Huang HH; Lin CY; Chiu CF
    Ann Hematol; 2008 May; 87(5):421-3. PubMed ID: 18040684
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe cutaneous ulceration following treatment with thalidomide for GVHD.
    Schlossberg H; Klumpp T; Sabol P; Herman J; Mangan K
    Bone Marrow Transplant; 2001 Jan; 27(2):229-30. PubMed ID: 11281398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide-induced orofacial neuropathy.
    Anyanwu CO; Stewart CL; Werth VP
    J Clin Rheumatol; 2014 Oct; 20(7):399-400. PubMed ID: 25275775
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuropathy in multiple myeloma treated with thalidomide: a prospective study.
    Plasmati R; Pastorelli F; Cavo M; Petracci E; Zamagni E; Tosi P; Cangini D; Tacchetti P; Salvi F; Bartolomei I; Michelucci R; Tassinari CA
    Neurology; 2007 Aug; 69(6):573-81. PubMed ID: 17679676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children.
    Rovelli A; Arrigo C; Nesi F; Balduzzi A; Nicolini B; Locasciulli A; Vassallo E; Miniero R; Uderzo C
    Bone Marrow Transplant; 1998 Mar; 21(6):577-81. PubMed ID: 9543061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide chemotherapy-induced peripheral neuropathy: actual status and new perspectives with thalidomide analogues derivatives.
    Cundari S; Cavaletti G
    Mini Rev Med Chem; 2009 Jun; 9(7):760-8. PubMed ID: 19519501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.
    Kulkarni S; Powles R; Sirohi B; Treleaven J; Saso R; Horton C; Atra A; Ortin M; Rudin C; Goyal S; Sankpal S; Meller S; Pinkerton CR; Mehta J; Singhal S
    Bone Marrow Transplant; 2003 Jul; 32(2):165-70. PubMed ID: 12838281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide neuropathy.
    Crawford CL
    N Engl J Med; 1992 Sep; 327(10):735. PubMed ID: 1323060
    [No Abstract]   [Full Text] [Related]  

  • 11. Thalidomide-induced neuropathy: treatment by decompression of peripheral nerves.
    Rose MI; Rosson GD; Elkwood AI; Dellon AL
    Plast Reconstr Surg; 2006 Jun; 117(7):2329-32. PubMed ID: 16772938
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacovigilance of patients with multiple myeloma being treated with bortezomib and/or thalidomide.
    Castro TB; Hallack Neto AE; Atalla A; Ribeiro LC
    Braz J Med Biol Res; 2016; 49(6):e5128. PubMed ID: 27254660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft-Versus-Lymphoma Effect Can Be Rapid and Potent in Diffuse Large B-Cell Lymphoma.
    Rashidi A; Cashen A
    Exp Clin Transplant; 2016 Aug; 14(4):460-2. PubMed ID: 27506261
    [No Abstract]   [Full Text] [Related]  

  • 14. Thalidomide-induced neuropathy.
    Crawford CL
    Mayo Clin Proc; 2002 Dec; 77(12):1395; author reply 1395. PubMed ID: 12479531
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Thalidomine neuropathy and leprous neuritis.
    Sabin TD
    Lancet; 1974 Feb; 1(7849):165-6. PubMed ID: 4129733
    [No Abstract]   [Full Text] [Related]  

  • 16. Thalidomide and sensory neurotoxicity: a neurophysiological study.
    Zara G; Ermani M; Rondinone R; Arienti S; Doria A
    J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1258-61. PubMed ID: 18450790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease.
    Chao NJ; Parker PM; Niland JC; Wong RM; Dagis A; Long GD; Nademanee AP; Negrin RS; Snyder DS; Hu WW; Gould KA; Tierney DK; Zwingenberger K; Forman SJ; Blume KG
    Biol Blood Marrow Transplant; 1996 May; 2(2):86-92. PubMed ID: 9118303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-Induced Peripheral Neuropathy Treated with Dorsal Root Ganglion Stimulation.
    Groenen PS; van Helmond N; Chapman KB
    Pain Med; 2019 Apr; 20(4):857-859. PubMed ID: 30412243
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous Lidocaine Infusion to Treat Chemotherapy-Induced Peripheral Neuropathy.
    Papapetrou P; Kumar AJ; Muppuri R; Chakrabortty S
    A A Case Rep; 2015 Nov; 5(9):154-5. PubMed ID: 26528700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide neuropathy: too much or too long?
    Apfel SC; Zochodne DW
    Neurology; 2004 Jun; 62(12):2158-9. PubMed ID: 15210874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.